It degrades the regulatory proteins, cyclin-dependent kinase inhibitors (e.g., p21 and p27), tumor suppressors (e.g., p53), and nuclear factor inhibitors (NF)-κB (e.g., IκB-α) that are necessary for tumor growth [67]. Here, TP53 is linked to neoplasm.